21 June 2024 : Original article
Long-Term Graft and Patient Survival After Re-Transplantation
Dana Bielopolski
12ACDEF*, Aviad Gravetz 34DE, Timna Agur 54E, Renana Yemini 2E, Benaya Rozen Zvi 54ACDE, Eviatar Nesher 64DE
DOI: 10.12659/AOT.943903
Ann Transplant 2024; 29:e943903
Table 3 Multiple regression for graft loss vs graft loss and death. Parameters include age, diabetes (DM), ischemic heart disease (IHD), panel-reactive antibody (PRA), living donor, donor age, delayed graft function (DGF), and hospitalization (HOSP).
| HR, 95% CI (graft loss and death) | HR, 95% CI (graft loss alone) | |
|---|---|---|
| Age | 1.021 (1.012–1.029) | 0.990 (0.979–1.001) |
| Gender | 0.868 (0.704–1.071) | 0.772 (0.568–1.047) |
| Time on dialysis | 1.002 (0.999–1.004) | 1.000 (0.996–1.003) |
| IHD | 1.496 (1.194–1.874) | 1.574 (1.086–2.281) |
| DM | 1.271 (1.022–1.581) | 0.663 (0.444–0.989) |
| PRA | 1.305 (0.990–1.720) | 1.589 (1.088–2.319) |
| Living donor | 0.467 (0.370–0.588) | 0.403 (0.285–0.570) |
| Donor age | 1.013 (1.006–1.019) | 1.018 (1.008–1.028) |
| DGF | 1.483 (1.177–1.867) | 1.812 (1.296–2.535) |
| HOSP | 1.006 (1.002–1.009) | 1.005 (1.000–1.010) |